Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia (Q45111042)

9 December 2017

title

Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia (English)

1 reference

9 December 2017

Kang HJ

1

1 reference

9 December 2017

Shin HY

series ordinal

2

1 reference

9 December 2017

Choi HS

series ordinal

3

1 reference

9 December 2017

Ahn HS

series ordinal

4

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Bone Marrow Transplantation

9 December 2017

published in

1 reference

9 December 2017

volume

34

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

939-943

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704720

9 December 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

A fludarabine-based conditioning regimen for severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704720

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704720

1 reference

Dimensions Publication ID

9 December 2017

1009369526

0 references

1 reference